FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2944477517> ?p ?o ?g. }

• W2944477517 endingPage "280" @default.
• W2944477517 startingPage "271" @default.
• W2944477517 abstract "In clinical trials for knee osteoarthritis (OAK), rescue medication is commonly provided to manage uncontrolled index-knee pain. The impact of treatment on rescue medication utilization provides important information on the robustness of analgesic effect. In randomized controlled OAK trials (NCT01487161, NCT02116972, NCT02357459), intra-articular (IA) triamcinolone acetonide extended-release (TA-ER) demonstrated substantial, prolonged analgesia versus saline-placebo and TA crystalline solution (TAcs) as assessed by patient-reported pain scales. This pooled analysis assessed the impact of TA-ER on rescue medication use.Patients (N = 798) with OAK (American College of Rheumatology criteria; Kellgren-Lawrence grade 2/3) and baseline average daily pain intensity score ≥ 5 to ≤ 9 (0-10 numeric rating scale) received a single IA injection of TA-ER (N = 324), saline-placebo (N = 262), or TAcs (N = 212). Acetaminophen/paracetamol tablets were provided to treat uncontrolled pain (knee or otherwise). Rescue medication consumption was monitored through a daily diary; pill counts were confirmed at the clinical site. Differences in rescue medication use were measured by least-squares mean (LSM) differences, number of rescue medication tablets used per day, and in area under the effect (AUE) curves of rescue medication tablets used per week.The overall number of rescue medication tablets used per day through week 24 was significantly less (p ≤ 0.05) for TA-ER versus saline-placebo (LSM difference, - 0.43) and TAcs (- 0.24). Rescue medication use was significantly (p ≤ 0.05) lower following TA-ER versus saline-placebo across weeks 1-12 (AUEweeks1-12; LSM difference, - 24.5) and weeks 1-24 (AUEweeks1-24; - 51.6) and versus TAcs across weeks 1-12 (AUEweeks1-12; - 21.1).In patients with painful OAK, reduced rescue medication use may be a potential benefit of TA-ER and further supports its analgesic efficacy. Additional research is needed to assess whether TA-ER impacts the use of other common oral analgesics (nonsteroidal anti-inflammatory drugs, opioids) for patients with OAK.Flexion Therapeutics, Inc., Burlington, MA, USA. Plain language summary available for this article." @default.
• W2944477517 created "2019-05-16" @default.
• W2944477517 creator A5004498996 @default.
• W2944477517 creator A5005459117 @default.
• W2944477517 creator A5016193083 @default.
• W2944477517 creator A5044968606 @default.
• W2944477517 creator A5082669130 @default.
• W2944477517 date "2019-05-07" @default.
• W2944477517 modified "2023-10-14" @default.
• W2944477517 title "Rescue Analgesic Medication Use by Patients Treated with Triamcinolone Acetonide Extended-Release for Knee Osteoarthritis Pain: Pooled Analysis of Three Phase 2/3 Randomized Clinical Trials" @default.
• W2944477517 cites W1495081997 @default.
• W2944477517 cites W1599185368 @default.
• W2944477517 cites W1885143646 @default.
• W2944477517 cites W1967057044 @default.
• W2944477517 cites W1981892168 @default.
• W2944477517 cites W1991767423 @default.
• W2944477517 cites W2007468708 @default.
• W2944477517 cites W2010818945 @default.
• W2944477517 cites W2029662381 @default.
• W2944477517 cites W2036491373 @default.
• W2944477517 cites W2044025770 @default.
• W2944477517 cites W2058147305 @default.
• W2944477517 cites W2143139033 @default.
• W2944477517 cites W2150215466 @default.
• W2944477517 cites W2161736885 @default.
• W2944477517 cites W2170079635 @default.
• W2944477517 cites W2320909684 @default.
• W2944477517 cites W2530841354 @default.
• W2944477517 cites W2582442420 @default.
• W2944477517 cites W2606554067 @default.
• W2944477517 cites W2765240768 @default.
• W2944477517 cites W2800248573 @default.
• W2944477517 cites W2890535036 @default.
• W2944477517 cites W3194956376 @default.
• W2944477517 cites W799912760 @default.
• W2944477517 doi "https://doi.org/10.1007/s40122-019-0125-1" @default.
• W2944477517 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6857100" @default.
• W2944477517 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31066021" @default.
• W2944477517 hasPublicationYear "2019" @default.
• W2944477517 type Work @default.
• W2944477517 sameAs 2944477517 @default.
• W2944477517 citedByCount "8" @default.
• W2944477517 countsByYear W29444775172019 @default.
• W2944477517 countsByYear W29444775172020 @default.
• W2944477517 countsByYear W29444775172021 @default.
• W2944477517 countsByYear W29444775172022 @default.
• W2944477517 countsByYear W29444775172023 @default.
• W2944477517 crossrefType "journal-article" @default.
• W2944477517 hasAuthorship W2944477517A5004498996 @default.
• W2944477517 hasAuthorship W2944477517A5005459117 @default.
• W2944477517 hasAuthorship W2944477517A5016193083 @default.
• W2944477517 hasAuthorship W2944477517A5044968606 @default.
• W2944477517 hasAuthorship W2944477517A5082669130 @default.
• W2944477517 hasBestOaLocation W29444775171 @default.
• W2944477517 hasConcept C126322002 @default.
• W2944477517 hasConcept C141071460 @default.
• W2944477517 hasConcept C142724271 @default.
• W2944477517 hasConcept C168563851 @default.
• W2944477517 hasConcept C197934379 @default.
• W2944477517 hasConcept C204787440 @default.
• W2944477517 hasConcept C27081682 @default.
• W2944477517 hasConcept C2776164576 @default.
• W2944477517 hasConcept C2777397205 @default.
• W2944477517 hasConcept C2778903070 @default.
• W2944477517 hasConcept C2780820201 @default.
• W2944477517 hasConcept C42219234 @default.
• W2944477517 hasConcept C535046627 @default.
• W2944477517 hasConcept C71924100 @default.
• W2944477517 hasConceptScore W2944477517C126322002 @default.
• W2944477517 hasConceptScore W2944477517C141071460 @default.
• W2944477517 hasConceptScore W2944477517C142724271 @default.
• W2944477517 hasConceptScore W2944477517C168563851 @default.
• W2944477517 hasConceptScore W2944477517C197934379 @default.
• W2944477517 hasConceptScore W2944477517C204787440 @default.
• W2944477517 hasConceptScore W2944477517C27081682 @default.
• W2944477517 hasConceptScore W2944477517C2776164576 @default.
• W2944477517 hasConceptScore W2944477517C2777397205 @default.
• W2944477517 hasConceptScore W2944477517C2778903070 @default.
• W2944477517 hasConceptScore W2944477517C2780820201 @default.
• W2944477517 hasConceptScore W2944477517C42219234 @default.
• W2944477517 hasConceptScore W2944477517C535046627 @default.
• W2944477517 hasConceptScore W2944477517C71924100 @default.
• W2944477517 hasIssue "2" @default.
• W2944477517 hasLocation W29444775171 @default.
• W2944477517 hasLocation W29444775172 @default.
• W2944477517 hasLocation W29444775173 @default.
• W2944477517 hasLocation W29444775174 @default.
• W2944477517 hasLocation W29444775175 @default.
• W2944477517 hasOpenAccess W2944477517 @default.
• W2944477517 hasPrimaryLocation W29444775171 @default.
• W2944477517 hasRelatedWork W1966127473 @default.
• W2944477517 hasRelatedWork W1983005718 @default.
• W2944477517 hasRelatedWork W1984882869 @default.
• W2944477517 hasRelatedWork W2022713662 @default.
• W2944477517 hasRelatedWork W2037344130 @default.
• W2944477517 hasRelatedWork W2375075125 @default.
• W2944477517 hasRelatedWork W2393648639 @default.
• W2944477517 hasRelatedWork W2552508825 @default.

• next